Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171782 | SCV000050740 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV000205866 | SCV000260271 | benign | Long QT syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620913 | SCV000735327 | benign | Cardiovascular phenotype | 2016-03-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Advanced Laboratory Medicine, |
RCV000853023 | SCV000995780 | benign | Cardiomyopathy; Ventricular fibrillation | 2019-05-20 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253269 | SCV002524870 | benign | Long QT syndrome 11 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000171782 | SCV002819813 | likely benign | not specified | 2022-12-25 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004712150 | SCV005269152 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000171782 | SCV001923205 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000171782 | SCV001957167 | benign | not specified | no assertion criteria provided | clinical testing |